Buy stocks
Invest and track all your stocks in one place.
Sun Pharma Advanced Research Co LtdNSE: SPARC
NSE: SPARC
₹211.20
+1.75
(4 Oct)
+0.8%
Loading chart
1D
1W
3M
1Y
5Y
Price
₹211.20
Today’s high
₹214.75
Today’s low
₹205.70
52W high
₹474.00
52W low
₹196.45
1Y
-9.7%
PE
-17.67
PB
54.50
EPS (TTM)
-11.93
Dividend yield
NA
5Y
8.7%
Market cap
₹6,853.9 Cr
Volume
72,334
Average volume
53,263
Insights
SPARC has made a new 52 Wk low. 52 Wk low stocks tend to underperform in the near term.
SPARC price is below its 200 day moving average
SPARC PB is in the highest 10% across all stocks. The market is valuing it as a growth stock based on its book value.
SPARC PE is in the low end of its range over the past 2 years
SPARC PE is in the lowest 10% across all stocks. The market is valuing it as a value stock on an earnings basis.
SPARC has negative earnings and hence the PE is not defined
SPARC is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
₹2,197.60
₹1,910.50
₹1,464.30
₹5,421.60
₹6,635.50
₹211.20
1D
+0.6%
-0.2%
+0.4%
-0.1%
-1.5%
+0.8%
1Y
+87.3%
+67.3%
+61.2%
+45.7%
+21.5%
-9.7%
PE
44.40
44.12
24.36
85.98
19.91
-17.67
PB
7.01
7.20
2.85
10.61
3.75
54.50
EPS
49.49
43.30
60.11
63.06
333.26
-11.95
Market cap
Large
Large
Large
Large
Large
Large
Financials
Income statement
Balance sheet
Cash flow
Quarterly
Annual
As of 2023
Revenue
₹75.5 Cr
Net income
- ₹387.2 Cr
See stock holdings
Top institutional holders
Vanguard Group Inc
0.56%
BlackRock Fund Advisors
0.45%
Quant Money Managers Limited
0.18%
Van Eck Associates Corporation
0.14%
State Street Global Advisors
0.14%
Top mutual fund holders
iShares Core MSCI Emerging Markets ETF
0.40%
Vanguard Total Intl Stock Idx Fund
0.25%
Vanguard Emerging Markets Stock Idx Fund
0.24%
Quant Small Cap Fund
0.22%
State Street Global Small Cap Eqty ExUS
0.13%
About SPARC
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.
Company address
Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Mumbai, MH, 400093

FAQs

How to Buy Sun Pharma Advanced Research Co Ltd Stock?
What is the Share Price of Sun Pharma Advanced Research Co Ltd?
What is the Market Cap of Sun Pharma Advanced Research Co Ltd?
In which sector / industry does Sun Pharma Advanced Research Co Ltd operate?
What was the revenue of Sun Pharma Advanced Research Co Ltd?
What is the PE ratio of Sun Pharma Advanced Research Co Ltd?
What is the 52 week high price of Sun Pharma Advanced Research Co Ltd?
What is the 52 week low price of Sun Pharma Advanced Research Co Ltd?
Can fractional shares of Sun Pharma Advanced Research Co Ltd be purchased?